Destiny Pharma Limited Is A Uk Based Clinical Stage Biotechnology Company Focused On Developing Innovative Anti Infectives For Infection Preventionestablished In 1996The Company Specializes In The Discoverydevelopmentand Commercialization Of Pharmaceuticals Aimed At Addressing Hospital Acquired Infections Destiny Pharma S Clinical Programs Include Ntcd M3A Microbiome Based Biotherapeutic Designed To Prevent The Recurrence Ofcdifficileinfectionsand Xf 73 Nasal Gelwhich Targets Post Surgical Staphylococcal Infectionsincluding Mrsaboth Products Are In Late Phase Clinical Developmentthe Company Also Has Earlier Stage Programs Under The Xf Platformwhich Includes Dermal Formulations For Various Indications With A Commitment To Addressing Antimicrobial Resistancedestiny Pharma Emphasizes Prophylactic Approaches To Infection Preventionthe Company Reported Limited Sales Activity In 2023Reflecting Its Focus On Advancing Its Clinical Pipeline
